Search

Your search keyword '"Gerrit Frommeyer"' showing total 228 results

Search Constraints

Start Over You searched for: Author "Gerrit Frommeyer" Remove constraint Author: "Gerrit Frommeyer"
228 results on '"Gerrit Frommeyer"'

Search Results

1. Lidocaine as an anti‐arrhythmic drug: Are there any indications left?

2. Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts

3. Safe electrophysiologic profile of dexmedetomidine in different experimental arrhythmia models

4. Permanent pacing in a very long‐term follow‐up after orthotopic heart transplantation: A matter of when or why?

5. Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia

6. Bradycardia in Patients with Subcutaneous Implantable Defibrillators—An Overestimated Problem? Experience from a Large Tertiary Centre and a Review of the Literature

7. Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure

8. Pulmonary Vein Isolation in Obese Compared to Non-Obese Patients: Real-Life Experience from a Large Tertiary Center

9. QTc evaluation in patients with bundle branch block

10. The Incidence, Electrophysiological Characteristics and Ablation Outcome of Left Atrial Tachycardias after Pulmonary Vein Isolation Using Three Different Ablation Technologies

11. Evidence-based treatment of atrial fibrillation around the globe: comparison of the latest ESC, AHA/ACC/HRS, and CCS guidelines on the management of atrial fibrillation

12. Improvement of Retinal Microcirculation after Pulmonary Vein Isolation in Patients with Atrial Fibrillation—An Optical Coherence Tomography Angiography Study

13. Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation

14. Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial Arrhythmia

15. The Effects of SEA0400 on Ca2+ Transient Amplitude and Proarrhythmia Depend on the Na+/Ca2+ Exchanger Expression Level in Murine Models

16. Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.

17. Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?

18. ESC-Leitlinie 2022: Management ventrikulärer Arrhythmien in der klinischen Praxis

20. In-hospital mortality and major complications related to radiofrequency catheter ablations of over 10 000 supraventricular arrhythmias from 2005 to 2020: individualized case analysis of multicentric administrative data

21. Predictors for major in-hospital complications after catheter ablation of ventricular arrhythmias: validation and modification of the Risk in Ventricular Ablation (RIVA) Score

23. Electrophysiological Safety Profile of Antiestrogenic Therapies in the Isolated Rabbit Heart

24. Detecting atrial fibrillation in the polysomnography-derived electrocardiogram: a software validation study

25. Experimental evidence for proarrhythmic effects of nonsteroidal anti‐inflammatory drugs in a sensitive whole‐heart model

26. [The new ESC guidelines on the management of ventricular tachyarrhythmias : Implications for daily practice]

27. Ocular perfusion in patients with reduced left ventricular ejection fraction measured by optical coherence tomography angiography

28. Predicting inappropriate S-ICD® episodes by simple 12-lead surface ECG parameters

29. Detection of Patients with Congenital and Often Concealed Long-QT Syndrome by Novel Deep Learning Models

30. Detection of Patients with Congenital and Often Concealed Long-QT Syndrome by Novel Deep Learning Models

31. [Electromagnetic interference in 3D-mapping procedures]

32. Usefulness of the MADIT-ICD Benefit Score in a Large Mixed Patient Cohort of Primary Prevention of Sudden Cardiac Death

33. Prospective blinded evaluation of smartphone-based ECG for differentiation of supraventricular tachycardia from inappropriate sinus tachycardia

34. Stellungnahme der Arbeitsgruppe Elektrophysiologie und Rhythmologie der Deutschen Gesellschaft für Kardiologie zu 3 Sicherheitshinweisen der Firma Boston Scientific für den subkutanen implantierbaren Kardioverter/Defibrillator (S-ICD) EMBLEMTM (Modell A209 und A219) sowie für die subkutane EMBLEMTM S-ICD-Elektrode (Modell 3501)

35. The ECG in sarcoidosis – a marker of cardiac involvement? Current evidence and clinical implications

36. Predictors of AVNRT Recurrence After Slow Pathway Modification

37. Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacing

38. Incidence and Predictors of Left Atrial Appendage Thrombus before Catheter Ablation of Thrombogenic Arrhythmias

39. Pitfalls of the S-ICD therapy: experiences from a large tertiary centre

40. Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model

41. One-Year Course of Periprocedural Anticoagulation in Atrial Fibrillation Ablation: Results of a German Nationwide Survey

42. QTc interval evaluation in patients with right bundle branch block or bifascicular blocks

43. The role of entirely subcutaneous ICD™ systems in patients with dilated cardiomyopathy

44. [Anatomy of the left ventricle for endocardial ablation]

45. Cardiovascular risk of energy drinks: Caffeine and taurine facilitate ventricular arrhythmias in a sensitive whole-heart model

46. Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'

47. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry

48. Very Long-Term Follow-Up in Cardiac Resynchronization Therapy: Wider Paced QRS Equals Worse Prognosis

49. Evidence-based treatment of atrial fibrillation around the globe: comparison of the latest ESC, AHA/ACC/HRS, and CCS guidelines on the management of atrial fibrillation

50. Quantifying Left Atrial Size in the Context of Atrial Fibrillation Ablation: Which Echocardiographic Method Correlates to Outcome of Pulmonary Venous Isolation?

Catalog

Books, media, physical & digital resources